Search research articles
Contact Us
Filters
Showing results (491-500 of 530) with videos related to
Page
of 53
Sort By:
NPJ Vaccines
|
June 1, 2019
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques
Patricia A Darrah, Robert M DiFazio, Pauline Maiello, et al.
Vaccine
|
June 7, 2015
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
Hennie Geldenhuys, Helen Mearns, David J C Miles, et al.
Scientific Reports
|
December 14, 2016
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants
Thorunn A Olafsdottir, Madelene Lindqvist, Intawat Nookaew, et al.
Nature Communications
|
August 2, 2022
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
Simon D van Haren, Gabriel K Pedersen, Azad Kumar, et al.
The Lancet. Gastroenterology & Hepatology
|
September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study
Nikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
Frontiers in Immunology
|
December 12, 2022
Multi-component prime-boost <i>Chlamydia trachomatis</i> vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model
Emma Lorenzen, Vanessa Contreras, Anja W Olsen, et al.
The Lancet. Infectious Diseases
|
August 17, 2019
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
Sonya Abraham, Helene B Juel, Peter Bang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 2017
Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents
Tobias Broger, Robindra Basu Roy, Angela Filomena, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 31, 2019
Genotypes of amyotrophic lateral sclerosis in Mongolia
Tselmen Daria, Kathrin Müller, Gansuvd Oidovdorj, et al.
Cell Reports
|
January 12, 2017
Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy
Gun-Sik Cho, Dong I Lee, Emmanouil Tampakakis, et al.
Page
of 53
Search research articles
Search
Showing results (491-500 of 530) with videos related to
Sort By:
Page
of 53
NPJ Vaccines
|
June 1, 2019
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques
Patricia A Darrah, Robert M DiFazio, Pauline Maiello, et al.
Vaccine
|
June 7, 2015
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
Hennie Geldenhuys, Helen Mearns, David J C Miles, et al.
Scientific Reports
|
December 14, 2016
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants
Thorunn A Olafsdottir, Madelene Lindqvist, Intawat Nookaew, et al.
Nature Communications
|
August 2, 2022
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
Simon D van Haren, Gabriel K Pedersen, Azad Kumar, et al.
The Lancet. Gastroenterology & Hepatology
|
September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study
Nikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
Frontiers in Immunology
|
December 12, 2022
Multi-component prime-boost <i>Chlamydia trachomatis</i> vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model
Emma Lorenzen, Vanessa Contreras, Anja W Olsen, et al.
The Lancet. Infectious Diseases
|
August 17, 2019
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
Sonya Abraham, Helene B Juel, Peter Bang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 2017
Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents
Tobias Broger, Robindra Basu Roy, Angela Filomena, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 31, 2019
Genotypes of amyotrophic lateral sclerosis in Mongolia
Tselmen Daria, Kathrin Müller, Gansuvd Oidovdorj, et al.
Cell Reports
|
January 12, 2017
Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy
Gun-Sik Cho, Dong I Lee, Emmanouil Tampakakis, et al.
Page
of 53